title: Licensing procedures for immunological veterinary medicinal products in the European Union.
abstract: With the adoption of the new authorization system, all regulatory needs for veterinary medicinal products have been fulfilled with the European Union. This system, indeed, provides access to a continent-wide market to innovative products, in particular vaccines, and facilitates access to the markets of the Member States for other products. This should have a clearly favorable impact on the veterinary vaccines industry.
authors.affiliation: Department of Immunology-Vaccinology, Faculty of Veterinary Medicine, University of Liège, Sart Tilman, Belgium.
authors.forename: P P
authors.initials: PP
authors.lastname: Pastoret
authors.forename: F
authors.initials: F
authors.lastname: Falize
mesh_terms: D000818:Animals; D005060:Europe; D005062:European Union; D006734:Horse Diseases / Q000276:immunology; D006736:Horses; D007252:Influenza Vaccines / Q000592:standards; D007886:Legislation, Veterinary; D008009:Licensure, Pharmacy / Q000331:legislation & jurisprudence*; D009976:Orthomyxoviridae Infections / Q000276:immunology / Q000662:veterinary; D010602:Pharmacopoeias as Topic; D014612:Vaccines / Q000592:standards*
chemical_list: D007252:Influenza Vaccines; D014612:Vaccines